Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vis AN et al. - In CRPC, prostate cancer cells still rely on intracellular androgens and on an active AR for growth and survival. CRPCs have gained mechanisms that enable them to use steroids from the circulation more efficiently through altered gene expression, and through a renewed and up-regulated synthesis of steroid hormone-converting enzymes. Additionally, CRPCs might synthesise AR isoforms that enable AR mediated processes independent from available androgens.


Today in Basic Science/Genetics...keeping you current

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Cancer Research, 11/03/09

Sexual Arousal by Higher- and Lower-Ranking Partner: Manifestation of a Mating Strategy
The Journal of Sexual Medicine, 11/03/09

Reduced Labial Temperature in Response to Sexual Films with Distractors among Women with Lower Sexual Desire
The Journal of Sexual Medicine, 11/03/09

Today in Endocrine...keeping you current

Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09

Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
BJU International, 11/17/09

Today in Oncology...keeping you current

Is statin use associated with prostate cancer aggressiveness
BJU International, 11/09/09

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

What comes after docetaxel
Der Urologe, 11/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address